
NanoEcho Investor Relations Material
Latest events

Q3 2024
NanoEcho

Q1 2025
30 Apr, 2025

Q4 2024
13 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from NanoEcho
Access all reports
NanoEcho is a Swedish medical technology company specializing in the development of diagnostic imaging solutions focused on cancer detection. The company is developing an advanced imaging system using magnetic nanoparticles to enhance the accuracy of detecting cancerous tissues, particularly for rectal cancer diagnostics. NanoEcho’s technology aims to provide non-invasive, precise imaging to improve diagnostic outcomes and patient care. Targeting healthcare providers, the company’s innovations are designed to aid in early cancer detection and streamline the diagnostic process. NanoEcho is headquartered in Lund, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
NANECH
Country
🇸🇪 Sweden